These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

591 related items for PubMed ID: 25275721

  • 21. Hydroxychloroquine retinopathy.
    Maturi RK, Folk JC, Nichols B, Oetting TT, Kardon RH.
    Arch Ophthalmol; 1999 Sep; 117(9):1262-3. PubMed ID: 10496407
    [No Abstract] [Full Text] [Related]

  • 22. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
    Browning DJ.
    Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706
    [Abstract] [Full Text] [Related]

  • 23. Pericentral hydroxychloroquine retinopathy in Korean patients.
    Lee DH, Melles RB, Joe SG, Lee JY, Kim JG, Lee CK, Yoo B, Koo BS, Kim JT, Marmor MF, Yoon YH.
    Ophthalmology; 2015 Jun; 122(6):1252-6. PubMed ID: 25712474
    [Abstract] [Full Text] [Related]

  • 24. Subjective and objective screening tests for hydroxychloroquine toxicity.
    Cukras C, Huynh N, Vitale S, Wong WT, Ferris FL, Sieving PA.
    Ophthalmology; 2015 Feb; 122(2):356-66. PubMed ID: 25444344
    [Abstract] [Full Text] [Related]

  • 25. Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss.
    Stepien KE, Han DP, Schell J, Godara P, Rha J, Carroll J.
    Trans Am Ophthalmol Soc; 2009 Dec; 107():28-33. PubMed ID: 20126479
    [Abstract] [Full Text] [Related]

  • 26. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
    Maturi RK, Yu M, Weleber RG.
    Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
    [Abstract] [Full Text] [Related]

  • 27. Value of red targets and pattern deviation plots in visual field screening for hydroxychloroquine retinopathy.
    Marmor MF, Chien FY, Johnson MW.
    JAMA Ophthalmol; 2013 Apr; 131(4):476-80. PubMed ID: 23710501
    [Abstract] [Full Text] [Related]

  • 28. A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy.
    Greenstein VC, Amaro-Quireza L, Abraham ES, Ramachandran R, Tsang SH, Hood DC.
    Doc Ophthalmol; 2015 Feb; 130(1):13-23. PubMed ID: 25502494
    [Abstract] [Full Text] [Related]

  • 29. Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity.
    Browning DJ.
    Am J Ophthalmol; 2002 May; 133(5):649-56. PubMed ID: 11992862
    [Abstract] [Full Text] [Related]

  • 30. Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease.
    Navajas EV, Krema H, Hammoudi DS, Lipton JH, Simpson ER, Boyd S, Easterbrook M.
    Can J Ophthalmol; 2015 Dec; 50(6):442-50. PubMed ID: 26651304
    [Abstract] [Full Text] [Related]

  • 31. Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?
    Aduriz-Lorenzo PM, Aduriz-Llaneza P, Araiz-Iribarren J, Khamashta MA.
    Lupus; 2020 Jun; 29(7):671-675. PubMed ID: 32316844
    [Abstract] [Full Text] [Related]

  • 32. Frequency and Clinical Characteristics of Hydroxychloroquine Retinopathy in Korean Patients with Rheumatologic Diseases.
    Eo DR, Lee MG, Ham DI, Kang SW, Lee J, Cha HS, Koh E, Kim SJ.
    J Korean Med Sci; 2017 Mar; 32(3):522-527. PubMed ID: 28145658
    [Abstract] [Full Text] [Related]

  • 33. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.
    Rodriguez-Padilla JA, Hedges TR, Monson B, Srinivasan V, Wojtkowski M, Reichel E, Duker JS, Schuman JS, Fujimoto JG.
    Arch Ophthalmol; 2007 Jun; 125(6):775-80. PubMed ID: 17562988
    [Abstract] [Full Text] [Related]

  • 34. Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.
    Missner S, Kellner U.
    Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):319-25. PubMed ID: 22215255
    [Abstract] [Full Text] [Related]

  • 35. Visual Field Sensitivity Prediction Using Optical Coherence Tomography Analysis in Hydroxychloroquine Toxicity.
    Jayakar G, De Silva T, Cukras CA.
    Invest Ophthalmol Vis Sci; 2022 Jan 03; 63(1):15. PubMed ID: 35015028
    [Abstract] [Full Text] [Related]

  • 36. The optical coherence tomography angiography findings of rheumatoid arthritis patients taking hydroxychloroquine.
    Ozek D, Onen M, Karaca EE, Omma A, Kemer OE, Coskun C.
    Eur J Ophthalmol; 2019 Sep 03; 29(5):532-537. PubMed ID: 30229672
    [Abstract] [Full Text] [Related]

  • 37. Hydroxychloroquine retinopathy.
    Yusuf IH, Sharma S, Luqmani R, Downes SM.
    Eye (Lond); 2017 Jun 03; 31(6):828-845. PubMed ID: 28282061
    [Abstract] [Full Text] [Related]

  • 38. Regular examinations for toxic maculopathy in long-term chloroquine or hydroxychloroquine users.
    Nika M, Blachley TS, Edwards P, Lee PP, Stein JD.
    JAMA Ophthalmol; 2014 Oct 03; 132(10):1199-208. PubMed ID: 24970348
    [Abstract] [Full Text] [Related]

  • 39. Risk of Retinal Toxicity in Longterm Users of Hydroxychloroquine.
    Kim JW, Kim YY, Lee H, Park SH, Kim SK, Choe JY.
    J Rheumatol; 2017 Nov 03; 44(11):1674-1679. PubMed ID: 28864645
    [Abstract] [Full Text] [Related]

  • 40. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
    Garrity ST, Jung JY, Zambrowski O, Pichi F, Su D, Arya M, Waheed NK, Duker JS, Chetrit Y, Miserocchi E, Giuffrè C, Kaden TR, Querques G, Souied EH, Freund KB, Sarraf D.
    Br J Ophthalmol; 2019 Nov 03; 103(11):1600-1604. PubMed ID: 30819690
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.